Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

NSAIDs and Salicylates: Classification and Clinical Implications

Classification and Mechanism of Action

  • The American Heart Association confirms that aspirin is classified specifically as a salicylic acid derivative, a subset of the broader NSAID category 3
  • NSAIDs are categorized into nine distinct chemical groups, including Salicylic Acid derivatives, which includes aspirin, sulfasalazine, and salsalate 1, 2
  • Most NSAIDs, including salicylates, work by inhibiting cyclooxygenase enzymes, but with varying selectivity for COX-1 vs. COX-2 1, 6

Clinical Implications and Recommendations

  • The American College of Cardiology recommends that all NSAIDs carry cardiovascular risks, but the risk varies by drug and is proportional to COX-2 selectivity 4, 5
  • The American College of Cardiology suggests a stepped-care approach for NSAID selection, starting with acetaminophen, small doses of narcotics, or non-acetylated salicylates 4, 5, 7
  • The American College of Cardiology advises that NSAIDs with increasing COX-2 selectivity should only be used when other options fail to provide adequate pain relief 4, 7

Safety Considerations

  • The American College of Cardiology notes that some NSAIDs like ibuprofen can block the antiplatelet effects of aspirin 5, 8
  • The American College of Cardiology warns that the risk of cardiovascular events with NSAIDs appears to be amplified in patients with established cardiovascular disease 4, 7

REFERENCES

1

Aspirin as a Salicylate [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025